US medical device contract manufacturer Biomerics is opening a new facility in Galway that will see the creation of around 40 jobs over the next five years.
The new 2,000 square foot balloon and balloon catheter center of excellence in Galway is Biomerics first facility in Europe and second facility outside the US after Costa Rica.
It will be dedicated to the development and manufacturing of balloons and balloon catheters and will act as an extension of operations in Athens, Texas.
Biomerics expansion here is supported by IDA Ireland.
Biomerics said it decided to locate in Galway because of the region’s significant group of medical device companies, a pool of skilled labor, an international reputation and access to suppliers and vendors.
“Having this new location is another step in our strategic growth plan. We continue to see a great need around the development of balloon components,” said Todd McFarland, president of Biomerics FMI.
“Our focus will be on next-generation technologies, including microballoons and sensors. In addition, the facility will provide more capacity to support our strategic customers in the interventionist markets we serve,” he added.
Michael Lohan, global director of life sciences at IDA Ireland, said Biomerics’ decision to locate its first European site in Galway is excellent news for Ireland and reflects the established life sciences cluster in the western region.
“This announcement is an example of IDA Ireland’s continued commitment to winning innovative investment and job creation in regional locations,” he added.
Galway-based Department of Transport Minister of State Hildegarde Naughton said the company’s decision to expand to Galway brings with it the creation of 40 jobs providing new opportunities for people to work and live in Galway, which has a proven track record in providing a rich talent pool with a highly skilled and educated workforce.
“Today’s announcement is a great achievement for the West of Ireland and points to a bright future for businesses across the country,” he added.